Home › YC Companies › Therapeutics Y Combinator Therapeutics Startups 64 Y Combinator-backed Therapeutics companies across 19 batches — with batch, status, and location for every startup.
Total 64
Active 53
Acquired 4
Public 0
Shut down 7 Y Combinator has backed 64 Therapeutics companies across 19 batches. Of these, 53 are still active, 4 have been acquired, 0 have gone public, and 7 have shut down. Below is every YC-backed Therapeutics startup grouped by batch, with links to each company profile.
FinalDose — Programmable DNA drug destroying all cancers, unlocking 80% of targets
WonderTx — Extrapolative AI to unlock First-in-Class drugs
Blank Bio — RNA intelligence for precision medicine
Evolvere BioSciences — Making Next-Generation Antibiotics that Outpace Bacterial Evolution Kopra Bio — Genetically engineered viruses that teach your immune system to kill…
Modulari-T — We teach your immune system to attack and cure cancer
Engage Bio — Potent, durable, and redosable non-viral genetic medicines Origami Therapeutics, Inc. — Oral drugs to halt neurodegeneration Alixia — Targeting the Tumor Ecosystem to address cancer drug resistance.
Altay Therapeutics — Altay develops disease-modifying therapies targeting transcription… OpenBiome — A nonprofit stool bank enabling access to fecal transplants. Equator Therapeutics — We are developing a drug to burn calories and increase metabolism… Ochre Bio — RNA medicines for liver diseases
Kernal Biologics — Kernal is creating mRNA 2.0 therapies that work in specific cells Nephrogen — Curative genetic medicines for kidney diseases
Forever Labs — We bank your stem cells to help you live healthier, longer.
Sigma Genetics — Sigma Genetics is a biotechnology company that is building… Loading interactive view…